WebGet BioCryst Pharmaceuticals Inc (BCRX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. WebMar 24, 2024 · RESEARCH TRIANGLE PARK, N.C. - BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) announced that oral, once-daily ORLADEYO (berotralstat) is now available for patients with a prescription in Germany. ORLADEYO was approved by the European Medicines Agency (EMA) on April 30, 2024 for the prevention of recurrent hereditary …
RBC Capital Sticks to Their Hold Rating for BioCryst (BCRX)
WebGet the latest BioCryst Pharmaceuticals Inc (BCRX) real-time quote, historical performance, charts, and other financial information to help you make more informed … WebBCRX Complete BioCryst Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. phoenix methadone
BioCryst Pharmaceuticals, Inc. (BCRX) Stock Price Today, Quote
WebApr 10, 2024 · BCRX Stock Overview. BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. ... Summary of all time highs, changes and price drops for BioCryst Pharmaceuticals; Historical stock prices; Current Share Price: US$8.52: 52 Week High: US$15.43: 52 Week Low: US$7.61: Beta: … WebGet BioCryst Pharmaceuticals, Inc. BO1.F price, chart, market capitalization and other stock info about BioCryst Pharmaceuticals, Inc.. Open this page to get detailed information about BO1.F traded on Frankfurt exchange in Germany WebApr 14, 2024 · Hedge funds and other institutional investors own 79.05% of the company's stock. BioCryst Pharmaceuticals Price Performance. Shares of NASDAQ BCRX opened at $8.41 on Friday. BioCryst Pharmaceuticals has a 1 year low of $7.61 and a 1 year high of $15.43. The company has a 50 day simple moving average of $8.97 and a 200 day … phoenix metro apwu